共 50 条
- [2] Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12): : 4817 - 4824
- [5] Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (05): : 635 - 647
- [6] Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2018, 38 (07): : 1190 - 1198
- [7] Octreotide (long-acting release formulation) treatment in patients with Graves' orbitopathy:: Clinical results of a four-month, randomized, placebo-controlled, double-blind study JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02): : 841 - 848
- [8] Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12): : 5910 - 5915
- [9] Fremanezumab Cardiovascular Safety Profile: Pooled Data from Placebo-controlled and Long-term Studies HEADACHE, 2018, 58 : 174 - 175
- [10] Long-acting morphine following hip or knee replacement: A randomized, double-blind, placebo-controlled trial PAIN RESEARCH & MANAGEMENT, 2012, 17 (02): : 83 - 88